Having trouble viewing this email? View in your browser.
img NEB invitation

Dear colleagues,

It is with great pleasure that I invite you to this dynamic Gilead-sponsored symposium.

Over a year since the COVID-19 pandemic began, multiple treatments have been explored, including antivirals and immunomodulators, with just a handful emerging as approved treatment options. In this fast-changing field, we aim to provide much-needed clarity about the role of antivirals in the management of hospitalised patients.

Using a combination of expert presentations, panel discussions and live Q&A, a faculty of internationally renowned experts will explore the role and timing of antiviral therapy in the treatment of COVID-19.

I look forward to welcoming you to what promises to be an engaging and informative session.

img Andrew Ustianowski

img Gilead
img NEB building

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.